Biogen agrees to pay $22 million to resolve alleged false claims act liability for paying kickbacks
Pharmaceutical company Biogen, Inc. (Biogen), based in Cambridge, Massachusetts, has agreed to pay $22 million to resolve claims that it violated the False Claims Act by illegally using foundations as a conduit to pay the copays...
Read More